Trial watch: local anesthetics in cancer therapy

References

• Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiol. 2008;109(2):180–19. doi:10.1097/ALN.0b013e31817f5b73.
   PubMed Web of Science ®Google Scholar
• Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiol. 2006;105(4):660–664. doi:10.1097/00000542-200610000-00008.
   PubMed Web of Science ®Google Scholar
• Vogelaar FJ, Abegg R, van der Linden Jc, Cornelisse HG, van Dorsten Fr, Lemmens VE, Bosscha K, van der Linden JC, van Dorsten FRC. Epidural analgesia associated with better survival in colon cancer. Int J Colorectal Dis. 2015;30(8):1103–1107. doi:10.1007/s00384-015-2224-8.
   PubMed Web of Science ®Google Scholar
• Li T, Chen L, Zhao H, Wu L, Masters J, Han C, Hirota K, Ma D. Both Bupivacaine and Levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro. J Anesth. 2019;33(1):17–25. doi:10.1007/s00540-018-2577-6.
   PubMed Web of Science ®Google Scholar
• Tat T, Jurj A, Selicean C, Pasca S, Ionescu D. Antiproliferative effects of propofol and lidocaine on the colon adenocarcinoma microenvironment. J BUON. 2019;24:106–115.
   PubMed Web of Science ®Google Scholar
• Zhu G, Zhang L, Dan J, Zhu Q. Differential effects and mechanisms of local anesthetics on esophageal carcinoma cell migration, growth, survival and chemosensitivity. BMC Anesthesiol. 2020;20(1):126. doi:10.1186/s12871-020-01039-1.
   PubMed Web of Science ®Google Scholar
• Castelli V, Piroli A, Marinangeli F, d’Angelo M, Benedetti E, Ippoliti R, Zis P, Varrassi G, Giordano A, Paladini A, et al. Local anesthetics counteract cell proliferation and migration of human triple-negative breast cancer and melanoma cells. J Cell Physiol. 2020;235(4):3474–3484. doi:10.1002/jcp.29236.
   PubMed Web of Science ®Google Scholar
• Zuckerman LM, Frames WL, Mirshahidi HR, Williams NL, Shields TG, Otoukesh S, Mirshahidi S. Antiproliferative effect of bupivacaine on patient-derived sarcoma cells. Mol Clin Oncol. 2020;13(3):7. doi:10.3892/mco.2020.2077.
   PubMed Web of Science ®Google Scholar
• Mammoto T, Higashiyama S, Mukai M, Mammoto A, Ayaki M, Mashimo T, Hayashi Y, Kishi Y, Nakamura H, Akedo H. Infiltration anesthetic lidocaine inhibits cancer cell invasion by modulating ectodomain shedding of heparin-binding epidermal growth factor-like growth factor (HB-EGF). J Cell Physiol. 2002;192(3):351–358. doi:10.1002/jcp.10145.
   PubMed Web of Science ®Google Scholar
• Johnson MZ, Crowley PD, Foley AG, Xue C, Connolly C, Gallagher HC, Buggy DJ. Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model. Br J Anaesth. 2018;121(1):76–85. doi:10.1016/j.bja.2017.12.043.
   PubMed Web of Science ®Google Scholar
• Wall TP, Crowley PD, Sherwin A, Foley AG, Buggy DJ. Effects of lidocaine and src inhibition on metastasis in a murine model of breast cancer surgery. Cancers (Basel). 2019;11(10):1414. doi:10.3390/cancers11101414.
   PubMed Web of Science ®Google Scholar
• Freeman J, Crowley PD, Foley AG, Gallagher HC, Iwasaki M, Ma D, Buggy DJ. Effect of perioperative lidocaine, propofol and steroids on pulmonary metastasis in a murine model of breast cancer surgery. Cancers. 2019;11(5):613. doi:10.3390/cancers11050613.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu M, Li Y, Wang H, Xu C, Zhang X, Li M, Guo H, Ma D, Guo X. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na(V) 1.5-mediated EMT and FAK/Paxillin signaling pathway. Cancer Med. 2021;10(1):337–349. doi:10.1002/cam4.3621.
   PubMed Web of Science ®Google Scholar
• D’Agostino G, Saporito A, Cecchinato V, Silvestri Y, Borgeat A, Anselmi L, Uguccioni M. Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration. Br J Anaesth. 2018;121(4):962–968. doi:10.1016/j.bja.2018.07.015.
   PubMed Web of Science ®Google Scholar
• Yin D, Liu L, Shi Z, Zhang L, Yang Y. Ropivacaine inhibits cell proliferation, migration and invasion, whereas induces oxidative stress and cell apoptosis by circSCAF11/miR-145-5p axis in glioma. Cancer Manag Res. 2020;12:11145–11155. doi:10.2147/CMAR.S274975.
   PubMed Web of Science ®Google Scholar
• Yoon JR, Whipple RA, Balzer EM, Cho EH, Matrone MA, Peckham M, Martin SS. Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells. Breast Cancer Res Treat. 2011;129(3):691–701. doi:10.1007/s10549-010-1239-7.
   PubMed Web of Science ®Google Scholar
• Xing B, Yang L, Cui Y. Lidocaine inhibited migration of NSCLCA549 cells via the CXCR4 regulation. Cancer Biomark. 2022;33(3):317–330. doi:10.3233/CBM-210249.
   PubMed Web of Science ®Google Scholar
• Leng T, Lin S, Xiong Z, Lin J. Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels. Int J Physiol Pathophysiol Pharmacol. 2017;9:8–15.
   PubMedGoogle Scholar
• Liu H, Dilger JP, Lin J. Lidocaine suppresses viability and migration of human breast cancer cells: TRPM7 as a target for some breast cancer cell lines. Cancers. 2021;13(2). doi:10.3390/cancers13020234.
   Web of Science ®Google Scholar
• Sun M, Huang S, Gao Y. Lidocaine inhibits the proliferation and metastasis of epithelial ovarian cancer through the Wnt/beta-catenin pathway. Transl Cancer Res. 2021;10(7):3479–3490. doi:10.21037/tcr-21-1047.
   PubMed Web of Science ®Google Scholar
• Dan J, Gong X, Li D, Zhu G, Wang L, Li F. Inhibition of gastric cancer by local anesthetic bupivacaine through multiple mechanisms independent of sodium channel blockade. Biomedicine Pharmacotherapy. 2018;103:823–828. doi:10.1016/j.biopha.2018.04.106.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng X, Zheng Q. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK. Biochem Biophys Res Commun. 2018;501(4):1074–1079. doi:10.1016/j.bbrc.2018.05.110.
   PubMed Web of Science ®Google Scholar
• Qin A, Liu Q, Wang J. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression. Drug Dev Res. 2020;81(6):700–707. doi:10.1002/ddr.21671.
   PubMed Web of Science ®Google Scholar
• Wang X, Li T. Ropivacaine inhibits the proliferation and migration of colorectal cancer cells through ITGB1. Bioengineered. 2021;12(1):44–53. doi:10.1080/21655979.2020.1857120.
   PubMed Web of Science ®Google Scholar
• Piegeler T, Schlapfer M, Dull RO, Schwartz DE, Borgeat A, Minshall RD, Beck-Schimmer B. Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFalpha-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. British J Anaesthesia. 2015;115(5):784–791. doi:10.1093/bja/aev341.
   PubMed Web of Science ®Google Scholar
• Shen J, Han L, Xue Y, Li C, Jia H, Zhu K. Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1alpha In Vitro. Front Pharmacol. 2021;12:806954. doi:10.3389/fphar.2021.806954.
   PubMed Web of Science ®Google Scholar
• Haraguchi-Suzuki K, Kawabata-Iwakawa R, Suzuki T, Suto T, Takazawa T, Saito S. Local anesthetic lidocaine induces growth suppression of HeLa cells by decreasing and changing the cellular localization of the proliferation marker Ki-67. Genes Cells. 2022;27(11):675–684. doi:10.1111/gtc.12983.
   PubMed Web of Science ®Google Scholar
• Bezu L, Wu Chuang A, Sauvat A, Humeau J, Xie W, Cerrato G, Liu P, Zhao L, Zhang S, Le Naour J, et al. Local anesthetics elicit immune-dependent anticancer effects. J Immunotherapy Cancer. 2022;10(4):e004151. doi:10.1136/jitc-2021-004151.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006;102(4):1103–1107. doi:10.1213/01.ane.0000198330.84341.35.
   PubMed Web of Science ®Google Scholar
• Ma XW, Li Y, Han XC, Xin QZ. The effect of low dosage of procaine on lung cancer cell proliferation. Eur Rev Med Pharmacol Sci. 2016;20:4791–4795.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang Y, Chen B, Shen X, Li W. Effects of lidocaine-mediated CPEB3 upregulation in human hepatocellular carcinoma cell proliferation in vitro. Biomed Res Int. 2018;2018:8403157. doi:10.1155/2018/8403157.
   PubMed Web of Science ®Google Scholar
• Teng X, Liu Y, Wang L, Wang G. Lidocaine exerts anticancer activity in bladder cancer by targeting isoprenylcysteine carboxylmethyltransferase (ICMT). Translational Andrology and Urology. 2021;10(11):4219–4230. doi:10.21037/tau-21-893.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Peng X, Zhang Y. Cytotoxicity of amide-linked local anesthetics on melanoma cells via inhibition of Ras and RhoA signaling independent of sodium channel blockade. BMC Anesthesiol. 2020;20(1):43. doi:10.1186/s12871-020-00957-4.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiao Z, Wang A, Zhong W. Lidocaine inhibits melanoma cell proliferation by regulating ERK phosphorylation. J Cell Biochem. 2019;120(4):6402–6408. doi:10.1002/jcb.27927.
   PubMed Web of Science ®Google Scholar
• Yang W, Cai J, Zhang H, Wang G, Jiang W. Effects of lidocaine and ropivacaine on gastric cancer cells through down-regulation of ERK1/2 phosphorylation in vitro. Anticancer Res. 2018;38(12):6729–6735. doi:10.21873/anticanres.13042.
   PubMed Web of Science ®Google Scholar
• Li C, Gao S, Li X, Li C, Ma L. Procaine inhibits the proliferation and migration of colon cancer cells through inactivation of the ERK/MAPK/FAK pathways by regulation of RhoA. Oncol Res. 2018;26(2):209–217. doi:10.3727/096504017X14944585873622.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hu R, Cheng Y, Wu X, Xi S, Sun Y, Jiang H. Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A. Cell Prolif. 2017;50(5). doi:10.1111/cpr.12364.
   Web of Science ®Google Scholar
• Le Gac G, Angenard G, Clement B, Laviolle B, Coulouarn C, Beloeil H. Local anesthetics inhibit the growth of human hepatocellular carcinoma cells. Anesth Analg. 2017;125(5):1600–1609. doi:10.1213/ANE.0000000000002429.
   PubMed Web of Science ®Google Scholar
• Kwakye AK, Kampo S, Lv J, Ramzan MN, Richard SA, Falagan AA, Agudogo J, Atito-Narh E, Yan Q, Wen QP. Levobupivacaine inhibits proliferation and promotes apoptosis of breast cancer cells by suppressing the PI3K/Akt/mTOR signalling pathway. BMC Res Notes. 2020;13(1):386. doi:10.1186/s13104-020-05191-2.
   PubMed Web of Science ®Google Scholar
• Tada M, Imazeki F, Fukai K, Sakamoto A, Arai M, Mikata R, Tokuhisa T, Yokosuka O. Procaine inhibits the proliferation and DNA methylation in human hepatoma cells. Hepatol Int. 2007;1(3):355–364. doi:10.1007/s12072-007-9014-5.
   PubMed Web of Science ®Google Scholar
• Wang HW, Wang LY, Jiang L, Tian SM, Zhong TD, Fang XM. Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer. J Thorac Dis. 2016;8(10):2748–2757. doi:10.21037/jtd.2016.09.66.
   PubMed Web of Science ®Google Scholar
• Xing W, Chen DT, Pan JH, Chen YH, Yan Y, Li Q, Xue RF, Yuan YF, Zeng WA. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells In vitro and in a xenograft model in vivo. Anesthesiol. 2017;126(5):868–881. doi:10.1097/ALN.0000000000001528.
   PubMed Web of Science ®Google Scholar
• Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R. Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol. 2018;18:33–42. doi:10.1016/j.redox.2018.05.014.
   PubMed Web of Science ®Google Scholar
• Zhang R, Lian Y, Xie K, Cai Y, Pan Y, Zhu Y. Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis. Bioengineered. 2021;12(2):9162–9173. doi:10.1080/21655979.2021.1995103.
   PubMed Web of Science ®Google Scholar
• Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling. J Biochem Mol Toxicol. 2021;35(10):e22871. doi:10.1002/jbt.22871.
   PubMed Web of Science ®Google Scholar
• Hao J, Zhang W, Huang Z. Bupivacaine modulates the apoptosis and ferroptosis in bladder cancer via phosphatidylinositol 3-kinase (PI3K)/AKT pathway. Bioengineered. 2022;13(3):6794–6806. doi:10.1080/21655979.2022.2036909.
   PubMed Web of Science ®Google Scholar
• Lu Y, Mao J, Xu Y, Pan H, Wang Y, Li W. Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway. Hum Exp Toxicol. 2022;41:9603271221120652. doi:10.1177/09603271221120652.
   Web of Science ®Google Scholar
• Lu J, Xu SY, Zhang QG, Xu R, Lei HY. Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways. European J Pharmacol. 2011;657(1–3):51–58. doi:10.1016/j.ejphar.2011.01.055.
   PubMed Web of Science ®Google Scholar
• Chang YC, Hsu YC, Liu CL, Huang SY, Hu MC, Cheng SP, Jiang Y. Local anesthetics induce apoptosis in human thyroid cancer cells through the mitogen-activated protein kinase pathway. PLoS One. 2014;9(2):e89563. doi:10.1371/journal.pone.0089563.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Y, Chen YJ, Liu Q. Anti-tumor effects of lidocaine on human gastric cancer cells in vitro. Bratisl Lek Listy. 2019;120(3):212–217. doi:10.4149/BLL_2019_036.
   PubMed Web of Science ®Google Scholar
• Sun H, Sun Y. Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis. Artif Cells Nanomed Biotechnol. 2019;47(1):2866–2874. doi:10.1080/21691401.2019.1636807.
   PubMed Web of Science ®Google Scholar
• Okamoto A, Tanaka M, Sumi C, Oku K, Kusunoki M, Nishi K, Matsuo Y, Takenaga K, Shingu K, Hirota K. The antioxidant N-acetyl cysteine suppresses lidocaine-induced intracellular reactive oxygen species production and cell death in neuronal SH-SY5Y cells. BMC Anesthesiol. 2016;16(1):104. doi:10.1186/s12871-016-0273-3.
   PubMedGoogle Scholar
• Li YC, Wang Y, Li DD, Zhang Y, Zhao TC, Li CF. Procaine is a specific DNA methylation inhibitor with anti-tumor effect for human gastric cancer. J Cell Biochem. 2018;119(2):2440–2449. doi:10.1002/jcb.26407.
   PubMed Web of Science ®Google Scholar
• Chang YC, Liu CL, Chen MJ, Hsu YW, Chen SN, Lin CH, Chen CM, Yang FM, Hu MC. Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg. 2014;118(1):116–124. doi:10.1213/ANE.0b013e3182a94479.
   PubMed Web of Science ®Google Scholar
• Mirshahidi S, Shields TG, de Necochea-Campion R, Yuan X, Janjua A, Williams NL, Mirshahidi HR, Reeves ME, Duerksen-Hughes P, Zuckerman LM. Bupivacaine and lidocaine induce apoptosis in osteosarcoma tumor cells. Clin Orthop Relat Res. 2021;479(1):180–194. doi:10.1097/CORR.0000000000001510.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu M, Xu Z, Li W, Dong X, Chen Y, Lin B, Li M. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity. Bio Res. 2019;52(1):36. doi:10.1186/s40659-019-0242-7.
   PubMed Web of Science ®Google Scholar
• Liang Y, Ji J, Lin Y, He Y, Liu J. The Ganglioside GM-1 Inhibits Bupivacaine-Induced Neurotoxicity in Mouse Neuroblastoma Neuro2a Cells. Cell Biochem Funct. 2016;34(6):455–462. doi:10.1002/cbf.3208.
   PubMed Web of Science ®Google Scholar
• Xuan W, Zhao H, Hankin J, Chen L, Yao S, Ma D. Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro. Sci Rep. 2016;6(1):26277. doi:10.1038/srep26277.
   PubMedGoogle Scholar
• Zhang H, Lin J, Hu T, Ren Z, Wang W, He Q. Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line. J Pharmacol Sci. 2019;139(3):186–192. doi:10.1016/j.jphs.2019.01.014.
   PubMed Web of Science ®Google Scholar
• Arita K, Utsumi T, Kato A, Kanno T, Kobuchi H, Inoue B, Akiyama J, Utsumi K. Mechanism of dibucaine-induced apoptosis in promyelocytic leukemia cells (HL-60). Bio Pharmacol. 2000;60(7):905–915. doi:10.1016/s0006-2952(00)00406-8.
   PubMed Web of Science ®Google Scholar
• Liu B, Yan X, Hou Z, Zhang L, Zhang D. Impact of Bupivacaine on malignant proliferation, apoptosis and autophagy of human colorectal cancer SW480 cells through regulating NF-kappaB signaling path. Bioengineered. 2021;12(1):2723–2733. doi:10.1080/21655979.2021.1937911.
   PubMed Web of Science ®Google Scholar
• Long D, Fang X, Yuan P, Cheng L, Li H, Qu L. Lidocaine promotes apoptosis in breast cancer cells by affecting VDAC1 expression. BMC Anesthesiol. 2022;22(1):273. doi:10.1186/s12871-022-01818-y.
   PubMed Web of Science ®Google Scholar
• Chen JL, Liu ST, Huang SM, Wu ZF. Apoptosis, Proliferation, and Autophagy Are Involved in Local Anesthetic-Induced Cytotoxicity of Human Breast Cancer Cells. Int J Mol Sci. 2022;23(24):15455. doi:10.3390/ijms232415455.
   PubMed Web of Science ®Google Scholar
• Long D, Chen Y, Qu L, Dong Y. Lidocaine inhibits the proliferation and migration of endometrial cancer cells, and promotes apoptosis by inducing autophagy. Oncol Lett. 2022;24(4):347. doi:10.3892/ol.2022.13467.
   PubMed Web of Science ®Google Scholar
• Qiao H, Zhang W, Liu P, Zhu R, Zhang J, Gao J, Li T, Zhang J. Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K/AKT pathway. J Biochem Mol Toxicol. 2023;37(1):e23233. doi:10.1002/jbt.23233.
   PubMed Web of Science ®Google Scholar
• Werdehausen R, Fazeli S, Braun S, Hermanns H, Essmann F, Hollmann MW, Bauer I, Stevens MF. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth. 2009;103(5):711–718. doi:10.1093/bja/aep236.
   PubMed Web of Science ®Google Scholar
• Mao SH, Zhu CH, Nie Y, Yu J, Wang L. Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer. Front pharmacol. 2021;12:681338. doi:10.3389/fphar.2021.681338.
   PubMedGoogle Scholar
• Sun D, Li YC, Zhang XY. Lidocaine promoted ferroptosis by targeting miR-382-5p /SLC7A11 axis in ovarian and breast cancer. Front pharmacol. 2021;12:681223. doi:10.3389/fphar.2021.681223.
   PubMed Web of Science ®Google Scholar
• Meng M, Huang M, Liu C, Wang J, Ren W, Cui S, Gu J, Xie J, Ma B, Yang G, et al. Local anesthetic levobupivacaine induces ferroptosis and inhibits progression by up-regulating p53 in non-small cell lung cancer. Aging (Albany NY). 2021;13. doi:10.18632/aging.203138.
   Google Scholar
• Liu J, Li J, Kang R, Tang D. Cell type-specific induction of ferroptosis to boost antitumor immunity. Oncoimmunol. 2023;12(1):2282252. doi:10.1080/2162402X.2023.2282252.
   PubMed Web of Science ®Google Scholar
• Demuynck R, Efimova I, Catanzaro E, Krysko DV. Ferroptosis: friend or foe in cancer immunotherapy? Oncoimmunol. 2023;12(1):2182992. doi:10.1080/2162402X.2023.2182992.
   PubMed Web of Science ®Google Scholar
• Sprooten J, Laureano RS, Vanmeerbeek I, Govaerts J, Naulaerts S, Borras DM, Kinget L, Fucikova J, Spisek R, Jelinkova LP, et al. Trial watch: chemotherapy-induced immunogenic cell death in oncology. Oncoimmunol. 2023;12(1):2219591. doi:10.1080/2162402X.2023.2219591.
   PubMed Web of Science ®Google Scholar
• Gu JH, Liu CC, Xie JL, Ma B, Cui SM, Yang GZ, He SC. The Local Anesthetic Bupivacaine Inhibits the Progression of Non-Small Cell Lung Cancer by Inducing Autophagy Through Akt/mTOR Signaling. Front Oncol. 2021;11:616445. doi:10.3389/fonc.2021.616445.
   PubMed Web of Science ®Google Scholar
• Lirk P, Berger R, Hollmann MW, Fiegl H. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. British J Anaesthesia. 2012;109(2):200–207. doi:10.1093/bja/aes128.
   PubMed Web of Science ®Google Scholar
• Villar-Garea A, Fraga MF, Espada J, Esteller M. Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res. 2003;63:4984–4989.
   PubMed Web of Science ®Google Scholar
• Sabit H, Samy MB, Said OA, El-Zawahri MM. Procaine induces epigenetic changes in HCT116 colon cancer cells. Genetics Res Int. 2016;2016:8348450. doi:10.1155/2016/8348450.
   PubMedGoogle Scholar
• Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. British J Anaesthesia. 2014;113 Suppl 1:i32–8. doi:10.1093/bja/aeu201.
   PubMed Web of Science ®Google Scholar
• Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablons DM, You L. Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells. Oncol Rep. 2009;22(6):1479–1484. doi:10.3892/or_00000590.
   PubMed Web of Science ®Google Scholar
• Qu X, Yang L, Shi Q, Wang X, Wang D, Wu G. Lidocaine inhibits proliferation and induces apoptosis in colorectal cancer cells by upregulating mir-520a-3p and targeting EGFR. Pathol Res Pract. 2018;214(12):1974–1979. doi:10.1016/j.prp.2018.09.012.
   PubMed Web of Science ®Google Scholar
• Xia W, Wang L, Yu D, Mu X, Zhou X. Lidocaine inhibits the progression of retinoblastoma in vitro and in vivo by modulating the miR–520a–3p/EGFR axis. Mol Med Rep. 2019;20(2):1333–1342. doi:10.3892/mmr.2019.10363.
   PubMed Web of Science ®Google Scholar
• Sui H, Lou A, Li Z, Yang J. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145. BMC Cancer. 2019;19(1):233. doi:10.1186/s12885-019-5431-9.
   PubMedGoogle Scholar
• Zhang N, Xing X, Gu F, Zhou G, Liu X, Li B. Ropivacaine inhibits the growth, migration and invasion of gastric cancer through attenuation of WEE1 and PI3K/AKT signaling via miR-520a-3p. Onco Targets Ther. 2020;13:5309–5321. doi:10.2147/OTT.S244550.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Q, Lu J, Cao J, Wang XY, Chen Y. Lidocaine promotes autophagy of SH-SY5Y cells through inhibiting PI3K/AKT/mTOR pathway by upregulating miR-145. Toxicol Res. 2020;9(4):467–473. doi:10.1093/toxres/tfaa049.
   PubMed Web of Science ®Google Scholar
• Ju C, Zhou J, Miao H, Chen X, Zhang Q. Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis. BMC Anesthesiol. 2020;20(1):275. doi:10.1186/s12871-020-01179-4.
   PubMed Web of Science ®Google Scholar
• Lin CY, Tseng WT, Chang YY, Tsai MH, Chuang EY, Lu TP, Lai LC. Lidocaine and bupivacaine downregulate MYB and DANCR lncRNA by upregulating miR-187-5p in MCF-7 cells. Front Med (Lausanne). 2021;8:732817. doi:10.3389/fmed.2021.732817.
   PubMed Web of Science ®Google Scholar
• Zhu J, Han S. Lidocaine inhibits cervical cancer cell proliferation and induces cell apoptosis by modulating the lncRNA-MEG3/miR-421/BTG1 pathway. Am J Transl Res. 2019;11:5404–5416.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ma N, Liu G, Mao N, Chen F, Li J. Lidocaineinhibits hepatocellular carcinoma development by modulating circ_ITCH/miR-421/CPEB3 axis. Dig Dis Sci. 2021;66(12):4384–4397. doi:10.1007/s10620-020-06787-1.
   PubMed Web of Science ®Google Scholar
• Guan E, Liu H, Xu N. Lidocaine suppresses gastric cancer development through circ_ANO5/miR-21-5p/LIFR axis. Dig Dis Sci. 2022;67(6):2244–2256. doi:10.1007/s10620-021-07055-6.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang X, Li Y, Li Y, Pang T. Lidocaine hampers colorectal cancer process via circITFG2/miR-1204/SOCS2 axis. Anticancer Drugs. 2022;33(3):235–244. doi:10.1097/CAD.0000000000001091.
   PubMed Web of Science ®Google Scholar
• Zi H, Chen L, Ruan Q. Lidocaine represses the malignant behavior of lung carcinoma cells via the circ_PDZD8/miR-516b-5p/GOLT1A axis. Histol Histopathol. 2022;37(5):461–474. doi:10.14670/HH-18-423.
   PubMed Web of Science ®Google Scholar
• Wen J, Li X, Ding Y, Zheng S, Xiao Y. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway. Neuroreport. 2021;32(1):52–60. doi:10.1097/WNR.0000000000001560.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu W, Guo X, Huang S, Song X. Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis. Oncol Rep. 2020;43(5):1659–1668. doi:10.3892/or.2020.7521.
   PubMed Web of Science ®Google Scholar
• Liu R, Wu M, Xu G, Ju L, Xiao J, Zhong W, He X, Yang Y. Ropivacaine inhibits proliferation, migration, and invasion while inducing apoptosis of glioma cells by regulating the SNHG16/miR-424-5p axis. Open Life Sci. 2020;15(1):988–999. doi:10.1515/biol-2020-0108.
   PubMed Web of Science ®Google Scholar
• Lu Y, Yang C, Zhang L, Ding J. Ropivacaine retards the viability, migration, and invasion of choriocarcinoma cells by regulating the long noncoding RNA OGFRP1/MicroRNA-4731-5p/HIF3A axis. Mol Biotechnol. 2022;64(5):499–509. doi:10.1007/s12033-021-00429-1.
   PubMed Web of Science ®Google Scholar
• Deng Z, Jian Y, Cai H. Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis. Bioengineered. 2022;13(3):5975–5986. doi:10.1080/21655979.2022.2037955.
   PubMed Web of Science ®Google Scholar
• Zhao L, Han S, Hou J, Shi W, Zhao Y, Chen Y. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis. Aging (Albany NY). 2021;13(12):16341–16352. doi:10.18632/aging.203160.
   PubMedGoogle Scholar
• Wang Y, Xie J, Liu W, Zhang R, Huang S, Xing Y. Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells via upregulation of microRNA-493. Pharmazie. 2017;72(11):663–669. doi:10.1691/ph.2017.7616.
   PubMed Web of Science ®Google Scholar
• Liu T, Jiang F, Yu LY, Wu YY. Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation. Bioengineered. 2022;13(3):6359–6370. doi:10.1080/21655979.2022.2031419.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang Z, Xu H, Ma C. Lidocaine alleviates cytotoxicity-resistance in lung cancer A549/DDP cells via down-regulation of miR-21. Mol Cell Biochem. 2019;456(1–2):63–72. doi:10.1007/s11010-018-3490-x.
   PubMed Web of Science ®Google Scholar
• Zhang X, Gu G, Li X, Zhang C. Lidocaine alleviates cisplatin resistance and inhibits migration of MGC-803/DDP cells through decreasing miR-10b. Cell Cycle. 2020;19(19):2530–2537. doi:10.1080/15384101.2020.1809914.
   PubMed Web of Science ®Google Scholar
• Cata JP, Ramirez MF, Velasquez JF, Di AI, Popat KU, Gottumukkala V, Black DM, Lewis VO, Vauthey JN. Lidocaine stimulates the function of natural killer cells in different experimental settings. Anticancer Res. 2017;37(9):4727–4732. doi:10.21873/anticanres.11879.
   PubMed Web of Science ®Google Scholar
• Ramirez MF, Tran P, Cata JP. The effect of clinically therapeutic plasma concentrations of lidocaine on natural killer cell cytotoxicity. Reg Anesth Pain Med. 2015;40(1):43–48. doi:10.1097/AAP.0000000000000191.
   PubMed Web of Science ®Google Scholar
• Wei Q, Xia M, Zhang Q, Wang Z. Effect of intravenous lidocaine infusion on perioperative cellular immunity and the quality of postoperative recovery in breast cancer patients: a randomized controlled trial. Gland Surg. 2022;11(3):599–610. doi:10.21037/gs-22-134.
   PubMed Web of Science ®Google Scholar
• Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009;109(5):1464–1469. doi:10.1213/ANE.0b013e3181bab1bd.
   PubMed Web of Science ®Google Scholar
• Wang HL, Yan HD, Liu YY, Sun BZ, Huang R, Wang XS, Lei WF. Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy. Mole Med Rep. 2015;12(5):7039–7044. doi:10.3892/mmr.2015.4235.
   PubMed Web of Science ®Google Scholar
• Dong H, Zhang Y, Xi H. The effects of epidural anaesthesia and analgesia on natural killer cell cytotoxicity and cytokine response in patients with epithelial ovarian cancer undergoing radical resection. J Int Med Res. 2012;40(5):1822–1829. doi:10.1177/030006051204000520.
   PubMed Web of Science ®Google Scholar
• Zhou D, Gu FM, Gao Q, Li QL, Zhou J, Miao CH. Effects of anesthetic methods on preserving anti-tumor T-helper polarization following hepatectomy. World J Gastroenterol. 2012;18(24):3089–3098. doi:10.3748/wjg.v18.i24.3089.
   PubMed Web of Science ®Google Scholar
• Zheng N, Wang T, Luo Q, Liu Y, Yang J, Zhou Y, Xie G, Ma Y, Yuan X, Shen L. M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance. Oncoimmunol. 2023;12(1):2210959. doi:10.1080/2162402X.2023.2210959.
   PubMed Web of Science ®Google Scholar
• Barnestein R, Galland L, Kalfeist L, Ghiringhelli F, Ladoire S, Limagne E. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness. Oncoimmunol. 2022;11(1):2120676. doi:10.1080/2162402X.2022.2120676.
   PubMed Web of Science ®Google Scholar
• Liu P, Chen J, Zhao L, Hollebecque A, Kepp O, Zitvogel L, Kroemer G. PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer. Oncoimmunol. 2022;11(1):2093518. doi:10.1080/2162402X.2022.2093518.
   PubMed Web of Science ®Google Scholar
• Gong X, Dan J, Li F, Wang L. Suppression of mitochondrial respiration with local anesthetic ropivacaine targets breast cancer cells. Journal of Thoracic Disease. 2018;10(5):2804–2812. doi:10.21037/jtd.2018.05.21.
   PubMed Web of Science ®Google Scholar
• Karniel M, Beitner R. Local anesthetics induce a decrease in the levels of glucose 1, 6-bisphosphate, fructose 1,6-bisphosphate, and ATP, and in the viability of melanoma cells. J Thorac Dis. 2000;69(1):40–45. doi:10.1006/mgme.1999.2954.
   Google Scholar
• Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiol. 2001;94(6):1066–1073. doi:10.1097/00000542-200106000-00022.
   PubMed Web of Science ®Google Scholar
• Deegan CA, Murray D, Doran P, Moriarty DC, Sessler DI, Mascha E, Kavanagh BP, Buggy DJ. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med. 2010;35(6):490–495. doi:10.1097/AAP.0b013e3181ef4d05.
   PubMed Web of Science ®Google Scholar
• Sultan SS. Paravertebral block can attenuate cytokine response when it replaces general anesthesia for cancer breast surgeries. Saudi J Anaesth. 2013;7(4):373–377. doi:10.4103/1658-354X.121043.
   PubMedGoogle Scholar
• Kuo CP, Jao SW, Chen KM, Wong CS, Yeh CC, Sheen MJ, Wu CT. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. British J Anaesthes. 2006;97(5):640–646. doi:10.1093/bja/ael217.
   PubMed Web of Science ®Google Scholar
• Zhao T, Xia WH, Zheng MQ, Lu CQ, Han X, Sun YJ. Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model. Exper Oncol. 2008;30:60–64.
   PubMedGoogle Scholar
• Kochhar A, Banday J, Ahmad Z, Panjiar P, Vajifdar H. Cervical epidural analgesia combined with general anesthesia for head and neck cancer surgery: a randomized study. J Anaesthesiol Clin Pharmacol. 2020;36(2):182–186. doi:10.4103/joacp.JOACP_72_19.
   PubMed Web of Science ®Google Scholar
• O’Riain SC, Buggy DJ, Kerin MJ, Watson RWG, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg. 2005;100(1):244–249. doi:10.1213/01.ANE.0000143336.37946.7D.
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis EG, Liu G, Place AT, Schwartz DE, Beck-Schimmer B, Minshall RD, Borgeat A. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiol. 2012;117(3):548–559. doi:10.1097/ALN.0b013e3182661977.
   PubMed Web of Science ®Google Scholar
• Chamaraux-Tran TN, Muller M, Pottecher J, Diemunsch PA, Tomasetto C, Namer IJ, Dali-Youcef N. Metabolomic Impact of Lidocaine on a Triple Negative Breast Cancer Cell Line. Front Pharmacol. 2022;13:821779. doi:10.3389/fphar.2022.821779.
   PubMed Web of Science ®Google Scholar
• Chen D, Yan Y, Xie J, Pan J, Chen Y, Li Q, Yuan Y, Zeng W, Xing W. Amide-type local anesthetics may suppress tumor cell proliferation and sensitize Human Hepatocellular Carcinoma Cells to Cisplatin via upregulation of RASSF1A expression and demethylation. J Cancer. 2020;11(24):7312–7319. doi:10.7150/jca.46630.
   PubMed Web of Science ®Google Scholar
• Zhang X, Pang W, Liu H, Wang J. Lidocine potentiates the cytotoxicity of 5-fluorouracil to choriocarcinoma cells by downregulating ABC transport proteins expression. J Cell Biochem. 2019;120(10):16533–16542. doi:10.1002/jcb.28913.
   PubMed Web of Science ®Google Scholar
• Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARbeta2 and RASSF1A demethylation. Int J Mol Sci. 2014;15(12):23519–23536. doi:10.3390/ijms151223519.
   PubMed Web of Science ®Google Scholar
• Freeman J, Crowley PD, Foley AG, Gallagher HC, Iwasaki M, Ma D, Buggy DJ. Effect of perioperative lidocaine and cisplatin on metastasis in a murine model of breast cancer surgery. Anticancer Res. 2018;38(10):5599–5606. doi:10.21873/anticanres.12894.
   PubMed Web of Science ®Google Scholar
• Viale M, Vannozzi MO, Mandys V, Esposito M. Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in P388 tumor bearing mice. Anticancer Res. 2001;21:485–487.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhao L, Li M, Yan L, Zhang S, Mi Z, Ren L, Xu J. Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer. Sci Rep. 2018;8(1):598. doi:10.1038/s41598-017-19026-x.
   PubMedGoogle Scholar
• Zeng W, Xing ZT, Tan MY, Wu YW, Zhang CY. Lidocaine suppresses the malignant behavior of gastric cancer cells via the c-Met/c-Src pathway. Exp Ther Med. 2021;21(5):424. doi:10.3892/etm.2021.9868.
   PubMed Web of Science ®Google Scholar
• Bezu L, Kepp O, Kroemer G. Local anesthetics and immunotherapy: a novel combination to fight cancer. Semin Immunopathol. 2023;45(2):265–272. doi:10.1007/s00281-022-00960-6.
   PubMed Web of Science ®Google Scholar
• Tang X, Li M, Wu X, Guo T, Zhang L, Tang L, Jia F, Hu Y, Zhang Y, Xing X, et al. Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer. Oncoimmunol. 2022;11(1):2135819. doi:10.1080/2162402X.2022.2135819.
   PubMed Web of Science ®Google Scholar
• Song M, Huang Y, Hong Y, Liu J, Zhu J, Lu S, Wang J, Sun F, Huang J, Xu J, et al. PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma. Oncoimmunol. 2024;13(1):2289738. doi:10.1080/2162402X.2023.2289738.
   PubMed Web of Science ®Google Scholar
• Russo M, Panini N, Fabbrizio P, Formenti L, Becchetti R, Matteo C, Meroni M, Nastasi C, Cappelleri A, Frapolli R, et al. Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells. Oncoimmunol. 2023;12(1):2239035. doi:10.1080/2162402X.2023.2239035.
   PubMed Web of Science ®Google Scholar
• Han BS, Jung KH, Lee JE, Yoon YC, Ko S, Park MS, Lee YJ, Kim SE, Cho YJ, Lee P, et al. Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer. Am J Cancer Res. 2022;12(7):3083–3098.
   PubMed Web of Science ®Google Scholar
• Holler JP, Ahlbrandt J, Burkhardt E, Gruss M, Rohrig R, Knapheide J, Hecker A, Padberg W, Weigand MA. Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): an analysis of a cancer registry. Ann Surg. 2013;258(6):989–993. doi:10.1097/SLA.0b013e3182915f61.
   PubMed Web of Science ®Google Scholar
• Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: a retrospective analysis. Br J Anaesth. 2011;106(6):814–822. doi:10.1093/bja/aer055.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang L, Zhu X, Zhu M, Sun Z, Cata JP, Chen W, Miao C. Association between intraoperative intravenous lidocaine infusion and survival in patients undergoing pancreatectomy for pancreatic cancer: a retrospective study. Br J Anaesth. 2020;125(2):141–148. doi:10.1016/j.bja.2020.03.034.
   PubMed Web of Science ®Google Scholar
• Wang X, Xie W, Gan S, Wang T, Chen X, Su D, Sun J, Lin J, Wu F, Xu P, et al. Effects of general anesthesia versus local anesthesia in primary hepatocellular carcinoma patients presenting for thermal ablation surgery: a multiple center retrospective cohort study with propensity score matching. Ann Transl Med. 2020;8(6):277. doi:10.21037/atm.2020.03.88.
   PubMed Web of Science ®Google Scholar
• Cummings KC 3rd, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiol. 2012;116(4):797–806. doi:10.1097/ALN.0b013e31824674f6.
   PubMed Web of Science ®Google Scholar
• Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CW, Vauthey JN. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2016;23(3):1003–1011. doi:10.1245/s10434-015-4933-1.
   PubMed Web of Science ®Google Scholar
• Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery. Acta Anaesthesiol Scand. 2014;58(3):281–290. doi:10.1111/aas.12255.
   PubMed Web of Science ®Google Scholar
• Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiol. 2010;113(1):27–34. doi:10.1097/ALN.0b013e3181de6d0d.
   PubMed Web of Science ®Google Scholar
• Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: a retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth. 2011;107(2):164–170. doi:10.1093/bja/aer100.
   PubMed Web of Science ®Google Scholar
• Merquiol F, Montelimard AS, Nourissat A, Molliex S, Zufferey PJ. Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: a retrospective propensity-matched analysis. Regional Anesthesia and Pain Medicine. 2013;38(5):398–402. doi:10.1097/AAP.0b013e31829cc3fb.
   PubMedGoogle Scholar
• Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE, Stueber F, Burkhard FC. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiol. 2010;113(3):570–576. doi:10.1097/ALN.0b013e3181e4f6ec.
   PubMed Web of Science ®Google Scholar
• Gao H, Meng XY, Wang HQ, Zhu FF, Guo AL, Zhu M, Song JC, Yu WF. Association between anaesthetic technique and oncological outcomes after colorectal carcinoma liver metastasis resection. Int. J. Med. Sci. 2019;16(2):337–342. doi:10.7150/ijms.28016.
   PubMed Web of Science ®Google Scholar
• Cazenave L, Faucher M, Tourret M, Marques M, Tezier M, Mokart D. Intravenous lidocaine and cancer outcomes after radical cystectomy. Eur. J. Anaesthesiol. 2022;39(4):396–399. doi:10.1097/EJA.0000000000001559.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gu J, Qu M, Sun Z, Huang Q, Cata JP, Chen W, Miao C. Effects of intravenous infusion of lidocaine on short-term outcomes and survival in patients undergoing surgery for ovarian cancer: a retrospective propensity score matching study. Front Oncol. 2021;11:689832. doi:10.3389/fonc.2021.689832.
   PubMed Web of Science ®Google Scholar
• Cummings Iii KC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS, Meropol NJ, Perry Y, Linden PA, Cummings LC. Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: a population-based retrospective cohort study. PLoS One. 2019;14(1):e0211125. doi:10.1371/journal.pone.0211125.
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Huang Q, Ye S, Rong T. Short and long-term outcomes of epidural or intravenous analgesia after esophagectomy: a propensity-matched cohort study. PLoS One. 2016;11(4):e0154380. doi:10.1371/journal.pone.0154380.
   PubMed Web of Science ®Google Scholar
• Wang J, Guo W, Wu Q, Zhang R, Fang J. Impact of combination epidural and general anesthesia on the long-term survival of gastric cancer patients: a retrospective study. Med Sci Monit. 2016;22:2379–2385. doi:10.12659/msm.899543.
   PubMed Web of Science ®Google Scholar
• de Oliveira Gs AS Jr., Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med. 2011;36(3):271–277. doi:10.1097/AAP.0b013e318217aada.
   PubMed Web of Science ®Google Scholar
• Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann. Surg. Oncol. 2015;22(4):1341–1348. doi:10.1245/s10434-014-4112-9.
   PubMed Web of Science ®Google Scholar
• Tseng JH, Cowan RA, Afonso AM, Zhou Q, Iasonos A, Ali N, Thompson E, Sonoda Y, O’Cearbhaill RE, Chi DS, et al. Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer. Gynecol Oncol. 2018;151(2):287–293. doi:10.1016/j.ygyno.2018.08.024.
   PubMed Web of Science ®Google Scholar
• Chen W, Xu Y, Zhang Y, Lou W, Han X. Positive impact of intraoperative epidural ropivacaine infusion on oncologic outcomes in pancreatic cancer patients undergoing pancreatectomy: a retrospective cohort study. J Cancer. 2021;12(15):4513–4521. doi:10.7150/jca.57661.
   PubMed Web of Science ®Google Scholar
• Chipollini J, Alford B, Boulware DC, Forget P, Gilbert SM, Lockhart JL, Pow-Sang JM, Sexton WJ, Spiess PE, Poch MA, et al. Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center. BMC Anesthesiol. 2018;18(1):157. doi:10.1186/s12871-018-0622-5.
   PubMedGoogle Scholar
• Cao L, Chang Y, Lin W, Zhou J, Tan H, Yuan Y, Zeng W. Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia. Anesth Analg. 2014;118(6):1309–1316. doi:10.1213/ANE.0000000000000207.
   PubMed Web of Science ®Google Scholar
• Binczak M, Tournay E, Billard V, Rey A, Jayr C. Major abdominal surgery for cancer: does epidural analgesia have a long-term effect on recurrence-free and overall survival? Ann Fr Anesth Reanim. 2013;32(5):e81–8. doi:10.1016/j.annfar.2013.02.027.
   PubMedGoogle Scholar
• Christopher Doiron R, Jaeger M, Booth CM, Wei X, Robert Siemens D. Is there a measurable association of epidural use at cystectomy and postoperative outcomes? a population-based study. Can Urol Assoc J. 2016;10(9–10):321–327. doi:10.5489/cuaj.3856.
   PubMed Web of Science ®Google Scholar
• Cata JP, Chavez-MacGregor M, Valero V, Black W, Black DM, Goravanchi F, Ifeanyi IC, Hernandez M, Rodriguez-Restrepo A, Gottumukkala V. The impact of paravertebral block analgesia on breast cancer survival after surgery. Reg Anesth Pain Med. 2016;41(6):696–703. doi:10.1097/AAP.0000000000000479.
   PubMed Web of Science ®Google Scholar
• Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth. 2010;105(2):145–149. doi:10.1093/bja/aeq156.
   PubMed Web of Science ®Google Scholar
• Wurster EF, Pianka F, Warschkow R, Antony P, Brenner T, Weigand MA, Schmied BM, Buchler MW, Tarantino I, Ulrich A. Peridural analgesia does not impact survival in patients after colon cancer resection: a retrospective propensity score-adjusted analysis. Int. J. Colorectal Dis. 2019;34(7):1283–1293. doi:10.1007/s00384-019-03315-0.
   PubMed Web of Science ®Google Scholar
• Wu HL, Tai YH, Mandell MS, Tsou MY, Yang SH, Chen TH, Chang KY. Effect of epidural analgesia on cancer prognosis after colon cancer resection: a single-centre cohort study in Taiwan. BMJ open. 2020;10(10):e036577. doi:10.1136/bmjopen-2019-036577.
   PubMed Web of Science ®Google Scholar
• Hasselager RP, Hallas J, Gogenur I. Epidural analgesia and recurrence after colorectal cancer surgery: a danish retrospective registry-based cohort study. Anesthesiol. 2022;136(3):459–471. doi:10.1097/ALN.0000000000004132.
   PubMed Web of Science ®Google Scholar
• Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth. 2012;109(2):185–190. doi:10.1093/bja/aes106.
   PubMed Web of Science ®Google Scholar
• Tai YH, Chang WK, Wu HL, Chan MY, Chen HH, Chang KY, Ahmad A. The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: a retrospective cohort study. PloS one. 2018;13(7):e0200893. doi:10.1371/journal.pone.0200893.
   PubMed Web of Science ®Google Scholar
• Heinrich S, Janitz K, Merkel S, Klein P, Schmidt J. Short- and long term effects of epidural analgesia on morbidity and mortality of esophageal cancer surgery. Langenbeck’s Arch. Surg. 2015;400(1):19–26. doi:10.1007/s00423-014-1248-9.
   PubMed Web of Science ®Google Scholar
• Cummings KC 3rd, Patel M, Htoo PT, Bakaki PM, Cummings LC, Koroukian S. A comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: a population-based study. Reg Anesth Pain Med. 2014;39(3):200–207. doi:10.1097/AAP.0000000000000079.
   PubMed Web of Science ®Google Scholar
• Pei JP, Zhang CD, Liang Y, Zhang C, Wu KZ, Zhao ZM, Dai DQ. Effects of epidural combined with general anesthesia versus general anesthesia alone in gastric cancer surgery: a propensity score matching analysis. Ann Transl Med. 2020;8(7):473. doi:10.21037/atm.2020.03.127.
   PubMed Web of Science ®Google Scholar
• Chang WK, Lee MY, Tai YH, Kuo YM, Tsou MY, Chang KY. Does epidural analgesia improve the cancer outcome in hepatocellular carcinoma after resection surgery? A retrospective analysis. J Chin Med Assoc. 2019;82(4):295–299. doi:10.1097/JCMA.0000000000000054.
   PubMed Web of Science ®Google Scholar
• Cata JP, Gottumukkala V, Thakar D, Keerty D, Gebhardt R, Liu DD. Effects of postoperative epidural analgesia on recurrence-free and overall survival in patients with nonsmall cell lung cancer. J Clin Anesth. 2014;26(1):3–17. doi:10.1016/j.jclinane.2013.06.007.
   PubMed Web of Science ®Google Scholar
• Wu HL, Tai YH, Chan MY, Tsou MY, Chen HH, Chang KY. Effects of epidural analgesia on cancer recurrence and long-term mortality in patients after non-small-cell lung cancer resection: a propensity score-matched study. BMJ open. 2019;9(5):e027618. doi:10.1136/bmjopen-2018-027618.
   PubMed Web of Science ®Google Scholar
• Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109(2):253–259. doi:10.1093/bja/aes176.
   PubMed Web of Science ®Google Scholar
• Lacassie HJ, Cartagena J, Branes J, Assel M, Echevarria GC. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population. Anesth Analg. 2013;117(3):653–660. doi:10.1213/ANE.0b013e3182a07046.
   PubMed Web of Science ®Google Scholar
• Capmas P, Billard V, Gouy S, Lhomme C, Pautier P, Morice P, Uzan C. Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer. Anticancer Res. 2012;32:1537–1542.
   PubMed Web of Science ®Google Scholar
• Lin KJ, Hsu FK, Shyr YM, Ni YW, Tsou MY, Chang KY. Effect of epidural analgesia on long-term outcomes after curative surgery for pancreatic cancer: a single-center cohort study in Taiwan. J Chin Med Assoc. 2022;85(1):124–128. doi:10.1097/JCMA.0000000000000615.
   PubMed Web of Science ®Google Scholar
• Alexander A, Lehwald-Tywuschik N, Rehders A, Rabenalt S, Verde PE, Eisenberger CF, Picker N, Knoefel WT, Kienbaum P. Peridural Anesthesia and Cancer-Related Survival after Surgery for Pancreatic Cancer-A Retrospective Cohort Study. Clin pract. 2021;11(3):532–542. doi:10.3390/clinpract11030070.
   PubMed Web of Science ®Google Scholar
• Wuethrich PY, Thalmann GN, Studer UE, Burkhard FC. Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer. PloS one. 2013;8(8):e72873. doi:10.1371/journal.pone.0072873.
   PubMed Web of Science ®Google Scholar
• Forget P, Tombal B, Scholtes JL, Nzimbala J, Meulders C, Legrand C, Van Cangh P, Cosyns JP, De Kock M. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol. 2011;28(12):830–835. doi:10.1097/EJA.0b013e32834b7d9a.
   PubMed Web of Science ®Google Scholar
• Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, Finucane BT. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth. 2010;57(2):107–112. doi:10.1007/s12630-009-9214-7.
   PubMed Web of Science ®Google Scholar
• Wu HL, Tai YH, Lin SP, Yang SH, Tsou MY, Chang KY. Epidural analgesia does not impact recurrence or mortality in patients after rectal cancer resection. Sci Rep. 2021;11(1):913. doi:10.1038/s41598-020-79657-5.
   PubMed Web of Science ®Google Scholar
• Shin S, Kim HI, Kim NY, Lee KY, Kim DW, Yoo YC. Effect of postoperative analgesia technique on the prognosis of gastric cancer: a retrospective analysis. Oncotarget. 2017;8(61):104594–104604. doi:10.18632/oncotarget.21979.
   PubMedGoogle Scholar
• Chen WK, Miao CH, Landoni G. The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PloS one. 2013;8(2):e56540. doi:10.1371/journal.pone.0056540.
   PubMed Web of Science ®Google Scholar
• Pei L, Tan G, Wang L, Guo W, Xiao B, Gao X, Wang L, Li H, Xu Z, Zhang X, et al. Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies. PloS one. 2014;9(12):e114667. doi:10.1371/journal.pone.0114667.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li T, Gan TJ. The effects of perioperative regional anesthesia and analgesia on cancer recurrence and survival after oncology surgery: a systematic review and meta-analysis. Reg Anesth Pain Med. 2015;40(5):589–598. doi:10.1097/AAP.0000000000000273.
   PubMed Web of Science ®Google Scholar
• Weng M, Chen W, Hou W, Li L, Ding M, Miao C. The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis. Oncotarget. 2016;7(12):15262–15273. doi:10.18632/oncotarget.7683.
   PubMedGoogle Scholar
• Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI, Investigators ATG. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ. 2011;342(mar29 2):d1491. doi:10.1136/bmj.d1491.
   PubMedGoogle Scholar
• Karmakar MK, Samy W, Lee A, Li JW, Chan WC, Chen PP, Tsui BCH. Survival analysis of patients with breast cancer undergoing a modified radical mastectomy with or without a thoracic paravertebral block: a 5-Year follow-up of a randomized controlled trial. Anticancer Res. 2017;37(10):5813–5820. doi:10.21873/anticanres.12024.
   PubMed Web of Science ®Google Scholar
• Finn DM, Ilfeld BM, Unkart JT, Madison SJ, Suresh PJ, Sandhu NPS, Kormylo NJ, Malhotra N, Loland VJ, Wallace MS, et al. Post-mastectomy cancer recurrence with and without a continuous paravertebral block in the immediate postoperative period: a prospective multi-year follow-up pilot study of a randomized, triple-masked, placebo-controlled investigation. Journal of Anesthesia. 2017;31(3):374–379. doi:10.1007/s00540-017-2345-z.
   PubMed Web of Science ®Google Scholar
• Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, Mayers DB, Meyer-Treschan TA, Grady M, Tan EY, et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. Lancet. 2019;394(10211):1807–1815. doi:10.1016/S0140-6736(19)32313-X.
   PubMed Web of Science ®Google Scholar
• MacFater WS, Xia W, Barazanchi AWH, MacFater HS, Lightfoot N, Svirskis D, Kahokehr AA, Hill AG. Association between perioperative intraperitoneal local anaesthetic infusion and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial. ANZ J Surg. 2020;90(5):802–806. doi:10.1111/ans.15753.
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim NK, Baik SH, Min BS, Hur H, Lee J, Noh HY, Lee JH, Koo BN. Effects of postoperative pain management on immune function after laparoscopic resection of colorectal cancer: a randomized study. Med. 2016;95(19):e3602. doi:10.1097/MD.0000000000003602.
   PubMed Web of Science ®Google Scholar
• Falk W, Magnuson A, Eintrei C, Henningsson R, Myrelid P, Matthiessen P, Gupta A. Comparison between epidural and intravenous analgesia effects on disease-free survival after colorectal cancer surgery: a randomised multicentre controlled trial. Br J Anaesth. 2021;127(1):65–74. doi:10.1016/j.bja.2021.04.002.
   PubMed Web of Science ®Google Scholar
• Xu D, Luo W. Effect of ropivacaine combined with small doses of triamcinolone and continuous nerve block of unilateral paravertebral canal guided by ultrasound on metastasis after radical treatment of lung cancer. J Oncol. 2022;2022:6310081. doi:10.1155/2022/6310081.
   PubMed Web of Science ®Google Scholar
• Xu ZZ, Li HJ, Li MH, Huang SM, Li X, Liu QH, Li J, Li XY, Wang DX, Sessler DI. Epidural anesthesia-analgesia and recurrence-free survival after lung cancer surgery: a randomized trial. Anesthesiol. 2021;135(3):419–432. doi:10.1097/ALN.0000000000003873.
   PubMed Web of Science ®Google Scholar
• Zhang H, Qu M, Guo K, Wang Y, Gu J, Wu H, Zhu X, Sun Z, Cata JP, Chen W, et al. Intraoperative lidocaine infusion in patients undergoing pancreatectomy for pancreatic cancer: a mechanistic, multicentre randomised clinical trial. Br J Anaesth. 2022;129(2):244–253. doi:10.1016/j.bja.2022.03.031.
   PubMed Web of Science ®Google Scholar
• Du YT, Li YW, Zhao BJ, Guo XY, Feng Y, Zuo MZ, Fu C, Zhou WJ, Li HJ, Liu YF, et al. Long-term survival after combined epidural-general anesthesia or general anesthesia alone: follow-up of a randomized trial. Anesthesiol. 2021;135(2):233–245. doi:10.1097/ALN.0000000000003835.
   PubMed Web of Science ®Google Scholar
• Ostovic H, Simac B, Prazetina M, Bradic N, Persec J. The effect of intravenous lidocaine, ketamine, and lidocaine-ketamine combination in colorectal cancer surgery: a randomized controlled trial. Anesth Analg. 2023. doi:10.1213/ANE.0000000000006555.
   PubMedGoogle Scholar
• Guerrero Orriach JL, Raigon Ponferrada A, Malo Manso A, Herrera Imbroda B, Escalona Belmonte JJ, Ramirez Aliaga M, Ramirez Fernandez A, Diaz Crespo J, Soriano Perez AM, Fontaneda Heredia A, et al. Anesthesia in combination with propofol increases disease-free survival in bladder cancer patients who undergo radical tumor cystectomy as compared to inhalational anesthetics and opiate-based analgesia. Oncology. 2020;98(3):161–167. doi:10.1159/000504807.
   PubMed Web of Science ®Google Scholar
• Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: a variation associated with choice of anesthesia. Anesth Analg. 2008;107(1):325–332. doi:10.1213/ane.0b013e3181770f55.
   PubMed Web of Science ®Google Scholar
• Alexa AL, Ciocan A, Zaharie F, Valean D, Sargarovschi S, Breazu C, Al Hajjar N, Ionescu D. The Influence of Intravenous Lidocaine Infusion on Postoperative Outcome and Neutrophil-to-Lymphocyte Ratio in Colorectal Cancer Patients. A Pilot Study. J. Gastrointest. Liver Dis. 2023;32(2):156–161. doi:10.15403/jgld-4962.
   PubMed Web of Science ®Google Scholar
• Wu YF, Li XP, Yu YB, Chen L, Jiang CB, Li DY, Chen ML. Postoperative local incision analgesia for acute pain treatment in patients with hepatocellular carcinoma. Rev. Assoc. Med. Bras. 2018;64(2):175–180. doi:10.1590/1806-9282.64.02.175.
   PubMed Web of Science ®Google Scholar
• Hayden JM, Oras J, Block L, Thorn SE, Palmqvist C, Salehi S, Nordstrom JL, Gupta A. Intraperitoneal ropivacaine reduces time interval to initiation of chemotherapy after surgery for advanced ovarian cancer: randomised controlled double-blind pilot study. Br J Anaesth. 2020;124(5):562–570. doi:10.1016/j.bja.2020.01.026.
   PubMed Web of Science ®Google Scholar
• Badwe RA, Parmar V, Nair N, Joshi S, Hawaldar R, Pawar S, Kadayaprath G, Borthakur BB, Rao Thammineedi S, Pandya S, et al. Effect of peritumoral infiltration of local anesthetic before surgery on survival in early breast cancer. J Clin Oncol. 2023;41(18):3318–3328. doi:10.1200/JCO.22.01966.
   PubMed Web of Science ®Google Scholar
• Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103(5):685–690. doi:10.1093/bja/aep261.
   PubMed Web of Science ®Google Scholar
• Vanni G, Materazzo M, Perretta T, Meucci R, Anemona L, Buonomo C, Dauri M, Granai AV, Rho M, Ingallinella S, et al. Impact of awake breast cancer surgery on postoperative lymphocyte responses. vivo. 2019;33(6):1879–1884. doi:10.21873/invivo.11681.
   PubMed Web of Science ®Google Scholar
• Xu YJ, Chen WK, Zhu Y, Wang SL, Miao CH. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. Br J Anaesth. 2014;113 Suppl 1:i49–55. doi:10.1093/bja/aeu148.
   PubMed Web of Science ®Google Scholar
• Wang L, Liang S, Chen H, Xu Y, Wang Y. The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection. BMC Anesthesiol. 2019;19(1):102. doi:10.1186/s12871-019-0778-7.
   PubMedGoogle Scholar
• Sen Y, Xiyang H, Yu H. Effect of thoracic paraspinal block-propofol intravenous general anesthesia on VEGF and TGF-beta in patients receiving radical resection of lung cancer. Med. 2019;98(47):e18088. doi:10.1097/MD.0000000000018088.
   PubMed Web of Science ®Google Scholar
• Hayden J, Gupta A, Thorn SE, Thulin P, Block L, Oras J. Does intraperitoneal ropivacaine reduce postoperative inflammation? A prospective, double-blind, placebo-controlled pilot study. Acta anaesthesiologica Scandinavica. 2019;63(8):1048–1054. doi:10.1111/aas.13410.
   PubMed Web of Science ®Google Scholar
• Huang XY, Wang HC, Yuan Z, Huang J, Zheng Q. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via beta-adrenergic receptor-dependent activation of P38/MAPK pathway. Hepato-gastroenterology. 2012;59(115):889–893. doi:10.5754/hge11476.
   PubMedGoogle Scholar
• Masur K, Niggemann B, Zanker KS, Entschladen F. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 2001;61:2866–2869.
   PubMed Web of Science ®Google Scholar
• Strell C, Niggemann B, Voss MJ, Powe DG, Zanker KS, Entschladen F. Norepinephrine promotes the beta1-integrin-mediated adhesion of MDA-MB-231 cells to vascular endothelium by the induction of a GROalpha release. Mol Cancer Res. 2012;10(2):197–207. doi:10.1158/1541-7786.MCR-11-0130.
   PubMed Web of Science ®Google Scholar
• An J, Feng L, Ren J, Li Y, Li G, Liu C, Yao Y, Yao Y, Jiang Z, Gao Y, et al. Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating beta-adrenergic signaling. Oncoimmunol. 2021;10(1):2004659. doi:10.1080/2162402X.2021.2004659.
   PubMed Web of Science ®Google Scholar
• Bezu L, Kepp O, Kroemer G. Immunogenic stress induced by local anesthetics injected into neoplastic lesions. Oncoimmunol. 2022;11(1):2077897. doi:10.1080/2162402X.2022.2077897.
   PubMed Web of Science ®Google Scholar
• Kudling TV, Clubb JHA, Quixabeira DCA, Santos JM, Havunen R, Kononov A, Heinio C, Cervera-Carrascon V, Pakola S, Basnet S, et al. Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression. Oncoimmunol. 2022;11(1):2096572. doi:10.1080/2162402X.2022.2096572.
   PubMed Web of Science ®Google Scholar
• Quixabeira DCA, Cervera-Carrascon V, Santos JM, Clubb JHA, Kudling TV, Basnet S, Heinio C, Gronberg-Vaha-Koskela S, Anttila M, Havunen R, et al. Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1. Oncoimmunol. 2022;11(1):2028960. doi:10.1080/2162402X.2022.2028960.
   PubMed Web of Science ®Google Scholar
• Jin C, Ali A, Iskantar A, Fotaki G, Wang H, Essand M, Karlsson-Parra A, Yu D. Intratumoral administration of pro-inflammatory allogeneic dendritic cells improved the anti-tumor response of systemic anti-CTLA-4 treatment via unleashing a T cell-dependent response. Oncoimmunol. 2022;11(1):2099642. doi:10.1080/2162402X.2022.2099642.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhou C, Li Q, Cheng X, Huang T, Li F, He L, Zhang B, Tu S. Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers. Oncoimmunol. 2022;11(1):2131084. doi:10.1080/2162402X.2022.2131084.
   PubMed Web of Science ®Google Scholar
• Brownlie D, von Kries A, Valenzano G, Wild N, Yilmaz E, Safholm J, Al-Ameri M, Alici E, Ljunggren HG, Schliemann I, et al. Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8(+) T cells towards the center of human lung tumors. Oncoimmunol. 2023;12(1):2233402. doi:10.1080/2162402X.2023.2233402.
   PubMed Web of Science ®Google Scholar
• Hassel JC, Schank TE, Smetak H, Muhlbauer J, Salzmann M, Machiraju D, Menzer C, Lang K, Konig L, Haefner MF, et al. Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA). Oncoimmunol. 2022;11(1):2066609. doi:10.1080/2162402X.2022.2066609.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Yang J, Ji J, Wang P, Zhang L, Yan G, Wu Y, Chen Q, Liu J, Zhang G, et al. PD-L1 blockade potentiates the antitumor effects of ALA-PDT and optimizes the tumor microenvironment in cutaneous squamous cell carcinoma. Oncoimmunol. 2022;11(1):2061396. doi:10.1080/2162402X.2022.2061396.
   PubMed Web of Science ®Google Scholar
• Steenbrugge J, Bellemans J, Vander Elst N, Demeyere K, De Vliegher J, Perera T, De Wever O, Van Den Broeck W, De Spiegelaere W, Sanders NN, et al. One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer. Oncoimmunol. 2022;11(1):2103277. doi:10.1080/2162402X.2022.2103277.
   PubMed Web of Science ®Google Scholar
• Sun N, Gong J, Zhang W, Yang X, Liu J. Sevoflurane suppresses hepatocellular carcinoma cell progression via circ_0001649/miR-19a-3p/SGTB axis. Histol Histopathol. 2023;38(5):537–547. doi:10.14670/HH-18-484.
   PubMed Web of Science ®Google Scholar
• Zhu X, Peng C, Peng Z, Chang R, Guo Q. Sevoflurane inhibits metastasis in hepatocellular carcinoma by inhibiting MiR-665-induced activation of the ERK/MMP pathway. Cell Transplant. 2022;31:9636897221104447. doi:10.1177/09636897221104447.
   Web of Science ®Google Scholar
• Kang X, Li X, Li Y. Sevoflurane suppresses the proliferation, migration and invasion of colorectal cancer through regulating circ_0000423/miR-525-5p/SGPP1 network. Cell Mol Bioeng. 2022;15(2):219–230. doi:10.1007/s12195-021-00717-5.
   PubMed Web of Science ®Google Scholar
• Reid P, Sandigursky S, Song J, Lopez-Olivo MA, Safa H, Cytryn S, Efuni E, Buni M, Pavlick A, Krogsgaard M, et al. Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases. Oncoimmunol. 2023;12(1):2261264. doi:10.1080/2162402X.2023.2261264.
   PubMed Web of Science ®Google Scholar